Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 28, 2023; 29(20): 3119-3132
Published online May 28, 2023. doi: 10.3748/wjg.v29.i20.3119
Published online May 28, 2023. doi: 10.3748/wjg.v29.i20.3119
Malignancy risk factors and prognostic variables of pancreatic mucinous cystic neoplasms in Chinese patients
Qing Xia, Rui Min, Nan Li, Department of Pathology, The First Affiliated Hospital of Bengbu Medical College, Bengbu Medical College, Bengbu 233004, Anhui Province, China
Fan Li, Shuai Sun, Department of Pathology, Bengbu Medical College, Bengbu 233030, Anhui Province, China
Yue-Xin Han, School of Clinical Medicine, Bengbu Medical College, Bengbu 233030, Anhui Province, China
Zhen-Zhong Feng, Nan Li, Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China
Author contributions: Xia Q collected the clinical data and prepared the manuscript; Xia Q and Li F designed the study and supervised the statistical data; Xia Q and Min R designed the research and contributed to the analyses; Sun S, Han YX, and Feng ZZ provided clinical advice; Li N made the pathologic diagnosis and supervised the report; and all authors read and approved the final version.
Supported by the Natural Science Key Project in Universities of Anhui Province , No. KJ2021A0701 ; Natural Science Key Project of Bengbu Medical College , No. 2020byzd030 ; and Postgraduate Scientific Research Innovation Program of the Bengbu Medical College , No. Byycx22016 .
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Bengbu Medical College (approval No. 2021085).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: We have no financial relationships to disclose.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Nan Li, Doctor, MD, PhD, Chief Doctor, Professor, Department of Pathology, The First Affiliated Hospital of Bengbu Medical College, No. 287 Changhuai Road, Bengbu 233004, Anhui Province, China. linanangel100@sina.com
Received: March 3, 2023
Peer-review started: March 3, 2023
First decision: April 12, 2023
Revised: April 21, 2023
Accepted: May 4, 2023
Article in press: May 4, 2023
Published online: May 28, 2023
Processing time: 84 Days and 6.2 Hours
Peer-review started: March 3, 2023
First decision: April 12, 2023
Revised: April 21, 2023
Accepted: May 4, 2023
Article in press: May 4, 2023
Published online: May 28, 2023
Processing time: 84 Days and 6.2 Hours
Core Tip
Core Tip: Pancreatic mucinous cystic neoplasms (MCNs) are a rare tumour with a low incidence and one of the precursor lesions of pancreatic ductal adenocarcinoma. The detection of MCN has been increasing by advances in imaging technology. MCNs associated risk factors, clinicopathological manifestations, and prognosis must be explored to improve our understanding of this rare tumour type and optimize clinical treatment.